| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAB41 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | MARCH6 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | HIP1R | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | ART4 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | GABRA5 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | MGMT | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | CYSLTR1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RGL4 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | TEX29 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | DLG3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
